W Szafrański
W Szafrański publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Political Science and International Relations, on topics such as Chronic Obstructive Pulmonary Disease (COPD) Research, Lung Cancer Treatments and Mutations and Historical and Cultural Studies of Poland.
- World rank
- #5,148,937 of 7,710,434 ranked researchers
- Rank in Germany
- #266,202 of 364,343
- Works
- 43
- Citations
- 1.1k
- Citations per work
- 26.2
What does W Szafrański research?
W Szafrański's work is mostly in Medicine (54%), Social Sciences (10%), Arts and Humanities (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2353.9%
- Medicine2353.9%
- Everything else1228.5%
- Social Sciences817.6%
- Social Sciences49.9%
- Arts and Humanities37.7%
- 1Pulmonary and Respiratory Medicine33% of their works
- 2Oncology12% of their works
- 3Political Science and International Relations10% of their works
- 4History8% of their works
- 5Radiology, Nuclear Medicine and Imaging6% of their works
- 6Public Health, Environmental and Occupational Health3% of their works
Research topics
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Lung Cancer Treatments and Mutations
- Historical and Cultural Studies of Poland
- Polish Historical and Cultural Studies
- Colorectal Cancer Treatments and Studies
- Respiratory Support and Mechanisms
- Lung Cancer Diagnosis and Treatment
- Gastrointestinal Tumor Research and Treatment
Which keywords describe W Szafrański's research?
The keywords of their largest research topics: Chemotherapy, COPD, spirometry, EGFR Mutations, Targeted Therapy, Eastern European culture, Polish history and Polish minority.
- Imatinib Mesylate
- Lung Cancer
- Acute Lung Injury
- Cetuximab
- Polish minority
- Eastern European culture
- EGFR Mutations
- Chemotherapy
- COPD
- spirometry
- Targeted Therapy
- Polish history
- Polish nobility
- KRAS Mutations
- CT Screening
- Mechanical Ventilation
- Sunitinib
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- COPD71 topic
- Chemotherapy72 topics
- spirometry71 topic
- EGFR Mutations61 topic
- Targeted Therapy61 topic
- Eastern European culture51 topic
- Polish history51 topic
- Polish minority51 topic
- Polish nobility51 topic
- Cetuximab41 topic
- KRAS Mutations41 topic
- Acute Lung Injury31 topic
- CT Screening31 topic
- Lung Cancer31 topic
- Mechanical Ventilation31 topic
- Imatinib Mesylate21 topic
- Sunitinib21 topic
Where does W Szafrański work?
W Szafrański's main affiliation in the publication record is Eli Lilly (Germany), Germany.
How many publications and citations does W Szafrański have?
OpenAlex counts 43 works and 1,126 citations for W Szafrański, an h-index of 6, ranking #5,148,937 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about W Szafrański. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.